Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

The Success of Personalized Anti-Cancer Therapies

Posted on January 4th, 2017 by in Pharma R&D

Every day, thousands of cancer patients face difficult choices about their treatment options. For those affected by advanced, stage 4 cancer, the decisions can be particularly painful. Continue reading “The Success of Personalized Anti-Cancer Therapies” »

An Update from Myelo: Expanding Our Team and Evaluating Data

Posted on December 14th, 2016 by in Pharma R&D

The focus of our current non-clinical research at Myelo Therapeutics is to fully elucidate the mode of action for prevention of myelosuppression as well as Myelo001’s antiviral capabilities. But to achieve this goal, it’s important to have highly skilled and motivated personnel within your team. Continue reading “An Update from Myelo: Expanding Our Team and Evaluating Data” »

The Latest in Bioinformatics Solutions

Posted on December 5th, 2016 by in Pharma R&D

Next generation sequencing and other innovative developments in biological research are helping scientists understand disease and drug activity at a level never before thought possible. Continue reading “The Latest in Bioinformatics Solutions” »

HIV Treatment: Dual Therapies and Dueling Companies

Posted on September 12th, 2016 by in Pharma R&D

After years of the AIDS epidemic taking a horrible toll on human life, some relief arrived in the 1990s as treatment for HIV, the virus that causes AIDS, came in the form of “cocktail” therapies that were developed by combining three or more antiretroviral drugs.

Continue reading “HIV Treatment: Dual Therapies and Dueling Companies” »

  1. 1
  2. 2